Skip to main content

Healthcare Reform Must Include Multiple Components

Web Exclusives - Practice Management

The current economic crisis offers an opportunity to focus on priorities in healthcare in an effort to enact true healthcare reform, said Len Nichols, PhD, healthcare economist and Director of the Health Policy Program at the New America Foundation, during the 2009 annual meeting of the American College of Cardiology (ACC).

The key components of healthcare reform will include not only expansion of coverage but also reform of delivery systems, payment reform, alignment of incentives, and reductions in the growth of healthcare costs. Expansion of coverage is estimated to cost $150 to $175 billion annually, or about 1% of gross national product.

In the end, “the cost of doing nothing is high,” said Dr Nichols. Business as usual will soon no longer be affordable, he said.

For payment reform to occur, investment in delivery systems will be necessary for health information technology research to compare the effectiveness of various strategies, as well as payment reform. “It is critical that we align incentives among providers, payers, and patients,” said Dr Nichols. Sharing risks and rewards in sustainable ways is key in the shift from the current fee-for-service system, he said. Malpractice reform and verification of quality care are other crucial components.

Dr Nichols warned of the danger of “brute-force price controls” in reform, and spoke of the importance of the appropriate use of technologies and procedures.

Along these lines, a separate symposium on appropriate use criteria underscored the value of appropriate use criteria in limiting the growth in healthcare spending.

The use of imaging procedures in particular has been growing more rapidly than other procedures, and represents an area that can be contained to reduce costs, said Pamela Douglas, MD, past president of the ACC and professor for research in cardiovascular diseases at Duke University in Durham, North Carolina.

Related Items
505(b)(2) Drugs: Creating New Chaos for Infusion Centers
Online First published on May 15, 2025 in Practice Management, Oncology
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS, Patricia R. Wigle, PharmD, Orson Austin, MD, Jeff Jianfei Guo, BPharm, PhD
Web Exclusives published on February 2, 2024 in Original Research, Practice Management, Health Policy and Reform
Employer Disability and Workers’ Compensation Trends for Their Employees With Ophthalmic Conditions in the United States
Richard A. Brook, MS, MBA, Nathan L. Kleinman, PhD, Ian A. Beren, BS
Web Exclusives published on August 21, 2023 in Original Research, Practice Management
Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Web Exclusives published on July 13, 2023 in Practice Management
Clinical and Financial Impacts of an Ambulatory Oncology Pharmacist–Based Intravenous Chemotherapy Education and Follow-Up Program
Grant W. Lee, PharmD, BCOP, Joseen J. Chundamala, PharmD, Kerri L. Monahan, PharmD, Judy J. Cho, PharmD, Lydia J. Berry, RPh, PharmD, Christine G. Cambareri, PharmD, BCOP, CSP
Web Exclusives published on July 6, 2023 in Original Research, Practice Management
Last modified: August 30, 2021